Article
Clonal Hematopoiesis of Indeterminate Potential and Atrial Fibrillation: Insights into Pathophysiology and Clinical Implications.
International journal of molecular sciences - 18 Mar 2025
Karakasis Paschalis, Theofilis Panagiotis, Lefkou Eleftheria, Antoniadis Antonios P, Patoulias Dimitrios, Korantzopoulos Panagiotis, Fragakis Nikolaos
Abstract excerpt
Clonal hematopoiesis of indeterminate potential (CHIP) has emerged as a novel risk factor for cardiovascular diseases. CHIP is characterized by the expansion of hematopoietic stem cell clones harboring somatic mutations in genes such as TET2, DNMT3A, and ASXL1, which are implicated in inflammation, atrial remodeling, and hypercoagulability. These mutations foster a pro-inflammatory and pro-thrombotic environment...
Read the complete abstract on PubMedTopics
- Humans
- Atrial Fibrillation
- Clonal Hematopoiesis
- Mutation
- Dioxygenases
- Animals
